• Ana Luisa Silveira Vieira, José Muniz Pazeli Júnior, and Marcus Gomes Bastos.
• Department of Nephrology, Santa Casa de Misericórdia de Barbacena and University of Medicine of Barbacena Department of Point of Care Ultrasound, Minas Gerais, Brazil. analuisasvieira@gmail.com.
• Ultrasound J. 2020 Jun 3; 12 (1): 30.

AbstractCOVID-19 is a viral disease due to the infection of the novel Corona virus SARS-CoV-2, that has rapidly spread in many countries until the World Health Organization declared the pandemic from March 11, 2020. Elderly patients and those affected by hypertension, diabetes mellitus, and chronic pulmonary and cardiovascular conditions are more susceptible to present more severe forms of COVID-19. These conditions are often represented in dialytic renal end-stage patients. Moreover, dialysis patients are more vulnerable to infection due to suppression of the immune system. Growing evidences, although still supported by few publications, are showing the potential utility of ultrasound in patients with COVID-19. In this review, we share our experience in using point-of-care ultrasound, particularly lung ultrasound, to indicate the probability of COVID-19 in patients with end-stage renal disease treated by hemodialysis. We also propose recommendations for the application of lung ultrasound, focused echocardiography and inferior vena cava ultrasound in the management of patients in hemodialysis.

5 keywords...

hide…